Free Trial
LON:EVG

Evgen Pharma (EVG) Share Price, News & Analysis

Evgen Pharma logo

About Evgen Pharma Stock (LON:EVG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
227,410 shs
Average Volume
1.73 million shs
Market Capitalization
£3.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EVG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evgen Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVG Stock News Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
TheraCryf Reports Positive SFX-01 Study Results
Passing of Dr Sue Foden, Chair
See More Headlines

EVG Stock Analysis - Frequently Asked Questions

Evgen Pharma plc (LON:EVG) announced its quarterly earnings results on Monday, June, 15th. The company reported ($2.10) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($2.10).

Shares of EVG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evgen Pharma investors own include genedrive (GDR), Motif Bio (MTFB), B&M European Value Retail (BME), Capital & Counties Properties PLC (CAPC), Coats Group (COA), 4D pharma (DDDD) and Greencore Group (GNC).

Company Calendar

Last Earnings
6/15/2020
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Financial Services
Current Symbol
LON:EVG
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£3.35 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-60.57%
Return on Assets
-45.52%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.39
Quick Ratio
23.15

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
1.71
Book Value
GBX 1 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
427,350,000
Free Float
N/A
Market Cap
£3.42 million
Optionable
Not Optionable
Beta
1.44
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (LON:EVG) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners